Belite Bio BLTE
NASDAQ BLTE
$193.81 +22.72 (+13.28%)
As of: Sep 4, 2026 · 3:59 PM EDT

Belite Bio (BLTE) Retained Earnings (2020 - 2025)

Belite Bio (BLTE) posted quarterly Retained Earnings of -$536000.0 for Q4 2025, up 99.5% year-over-year from -$268668.9 in Q4 2024, and up 99.66% quarter-over-quarter from -$159.9 million in Q3 2025.

Analysis

Belite Bio (BLTE) Retained Earnings (2020 - 2025) Analysis & Trends

Belite Bio's Retained Earnings history runs 6 years deep, the most recent figure standing at -$536000.0 for Q4 2025.

  • In Q4 2025, Retained Earnings rose 99.5% year-over-year to -$536000.0; the TTM figure through Dec 2025 stood at -$536000.0 (up 99.5% YoY), while the FY2025 annual figure was -$536000.0, up 99.5% from the prior year.
  • Retained Earnings for Q4 2025 stood at -$536000.0, up from -$159.9 million in the prior quarter.
  • The five-year high for Retained Earnings was -$196000.0 in Q4 2021, with the low at -$159.9 million in Q3 2025.
  • The 5-year median for Retained Earnings is -$55.7 million (2022), against an average of -$63.3 million.
  • The sharpest annual moves came in 2022 and 2025: Retained Earnings slumped 20242.35% in 2022, then soared 99.5% in 2025.
  • Belite Bio's Retained Earnings stood at -$196000.0 in 2021, then plunged by 20242.35% to -$39.9 million in 2022, then slumped by 79.34% to -$71.5 million in 2023, then tumbled by 50.55% to -$107.6 million in 2024, then jumped by 99.5% to -$536000.0 in 2025.
  • Business Quant data shows BLTE's Retained Earnings at -$536000.0 in Q4 2025, -$159.9 million in Q3 2025, and -$107.6 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Belite Bio 6.44 Bn 6.44 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 956.28 Mn
Sep 30, 2025 434.45 Mn
Dec 31, 2024 254.13 Mn
Dec 31, 2023 162.31 Mn
Dec 31, 2022 81.76 Mn
Dec 31, 2021 12.33 Mn
Dec 31, 2020 -17.60 Mn